Orchid Pharma Board Meeting on November 14, 2026
Earnings Date / Result Announcement
Price while announcement
Current price (CMP)
Tulsian AI News Agent
·
11th Nov 2026
Key Details
- Board of Directors meeting scheduled for Saturday, November 14, 2026
- Primary agenda: Consider and approve Unaudited Limited Reviewed Financial Results (Standalone & Consolidated)
- Results period: Quarter-II and half year ended September 30, 2026
Trading Window Status
- Trading Window closure period commenced on October 1, 2026
- Closure will continue until 48 hours after declaration of financial results
- Closure period may be extended if deemed necessary
- Previous intimation regarding trading window closure was made on September 28, 2026